Results 101 to 110 of about 540,208 (312)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Introducing polyautoimmunity: secondary autoimmune diseases no longer exist
, 2012 Similar pathophysiological mechanisms within autoimmune diseases have stimulated searches for common genetic roots. Polyautoimmunity is defined as the presence of more than one autoimmune disease in a single patient.
Rojas-Villarraga, Adriana +2 more
core
Autoimmune diseases and myelodysplastic syndromes
Autoimmune diseases (ADs) and myelodysplastic syndrome (MDS) may be associated in approximately 10–20% of cases. Although this association has been well recognized, it is not always easily diagnosed.
Melek Kechida, Arij Cheffai
core +1 more source
Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies.
, 2013 BACKGROUND: Previous studies have suggested that there may be an association between some immune-mediated diseases and risk of tuberculosis (TB). METHODS: We analyzed a database of linked statistical records of hospital admissions and death certificates ...
Michael J Goldacre +10 more
core +1 more source
Autoimmune Diseases in Humans, e.g. Autoimmune Rheumatic Diseases
Intervirology, 1993 In spite of increasing evidence that viruses and especially retroviruses could act as etiologic factors in autoimmune and especially autoimmune rheumatic diseases, clear-cut evidence for an involvement of these agents is still missing. Findings, which, for example, indirectly support the hypothesis that retroviruses might play a part, are the ...
J R, Kalden, M, Herrmann
openaire +2 more sources
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Narcolepsy type 1 (NT1) is caused by the loss of hypocretin‐1 leading to excessive daytime sleepiness and cataplexy. Additionally, disrupted nighttime sleep has become an increasingly recognized feature of NT1. As the glymphatic fluid movement has been linked to sleep architecture, we investigated cerebrospinal fluid (CSF) Aquaporin‐4 (AQP4 ...
Jonas Ranke +5 more
wiley +1 more source
Italian Journal of Pediatrics, 2017 Background Thyroid gland disorders are variably associated with Prader-Willi syndrome (PWS). Many of the clinical features in newborns with PWS are similar to those found in congenital hypothyroidism (CH).
Sarah Bocchini +5 more
doaj +1 more source
The kidney in systemic autoimmune diseases /
, 2008 This volume brings together an international group of clinicians and clinical scientists to contribute to a state-of the-art review of the underlying pathogenic mechanisms, methods of clinical assessment, classification and diagnosis of renal disease ...
Pusey, C. D., Mason, Justin C.
core
, 2005 This chapter discusses the women affected by systemic autoimmune diseases. Patients affected by systemic lupus erythematosus (SLE) are discouraged from becoming pregnant.
Cimaz R. +10 more
core +1 more source